Transient early-pluripotency treatment yields human iPSCs with stronger differentiation
A transient 4CL treatment during reprogramming yields human iPSCs with enhanced mesodermal, endodermal, and pancreatic differentiation capacity.
Tag: 4CL-primed strategy
POPULAR NEWS
-
Nursing decision support tool linked to lower neonatal hypoglycemia rates in hospital study
-
IVF Study Finds Progesterone-to-Oocyte Ratio Adds Little Beyond Its Parts
-
Mitochondrial Cleanup and a DNA Sensor May Team Up to Drive Stroke Inflammation
-
Smartphones, Glucose Sensors and Voice May Reveal Diabetic Minds, Review Finds